Preferred Label : Camurati-engelmann disease;
Symbol : CAEND;
CISMeF acronym : CAEND; CED; DPD1; PDD;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : PDD; Engelmann disease; CED; Diaphyseal dysplasia 1, progressive; DPD1; Progressive diaphyseal dysplasia;
Description : Camurati-Engelmann disease is a rare autosomal dominant type of bone bone dysplasia.
The hallmark of the disorder is the cortical thickening of the diaphyses of the long
bones. Hyperostosis is bilateral and symmetrical and usually starts at the diaphyses
of the femora and tibiae, expanding to the fibulae, humeri, ulnae, and radii. As the
disease progresses, the metaphyses may be affected as well, but the epiphyses are
spared. Sclerotic changes at the skull base may be present. The onset of the disease
is usually during childhood and almost always before the age of 30. Most patients
present with limb pain, muscular weakness, a waddling gait, and easy fatigability.
Systemic manifestations such as anemia, leukopenia, and hepatosplenomegaly occur occasionally
(summary by Janssens et al., 2006).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutations in the beta-1 transforming growth factor gene (TGFB1, 190180.0001);
Prefixed ID : #131300;
Origin ID : 131300;
UMLS CUI : C0011989;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)